Evidence map›Paper›PMID 29133410›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Unprecedented pathway of reducing equivalents in a diflavin-linked disulfide oxidoreductase.

Rubén M Buey, Juan B Arellano, Luis López-Maury, Sergio Galindo-Trigo, Adrián Velázquez-Campoy, José L Revuelta, José M de Pereda, Francisco J Florencio, Peter Schürmann, Bob B Buchanan and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Rubén M BueyMetabolic Engineering Group, Departamento de Microbiología y Genética, Universidad de Salamanca, 37007 Salamanca, Spain.
Juan B ArellanoInstituto de Recursos Naturales y Agrobiología de Salamanca, Consejo Superior de Investigaciones Científicas (CSIC), 37008 Salamanca, Spain.
Luis López-MauryInstituto de Bioquímica Vegetal y Fotosíntesis, Universidad de Sevilla-CSIC, 41092 Sevilla, Spain.
Sergio Galindo-TrigoInstituto de Recursos Naturales y Agrobiología de Salamanca, Consejo Superior de Investigaciones Científicas (CSIC), 37008 Salamanca, Spain.
Adrián Velázquez-CampoyInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, 50009 Zaragoza, Spain.
José L RevueltaMetabolic Engineering Group, Departamento de Microbiología y Genética, Universidad de Salamanca, 37007 Salamanca, Spain.
José M de PeredaInstituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain.
Francisco J FlorencioInstituto de Bioquímica Vegetal y Fotosíntesis, Universidad de Sevilla-CSIC, 41092 Sevilla, Spain.
Peter SchürmannLaboratoire de Biologie Moléculaire et Cellulaire, Université de Neuchâtel, 2000 Neuchâtel, Switzerland.
Bob B BuchananDepartment of Plant and Microbial Biology, University of California, 94720 Berkeley view@berkeley.edu monica.balsera@csic.es.
Monica BalseraInstituto de Recursos Naturales y Agrobiología de Salamanca, Consejo Superior de Investigaciones Científicas (CSIC), 37008 Salamanca, Spain; view@berkeley.edu monica.balsera@csic.es.
Universidad de Salamanca · ESConsejo Superior de Investigaciones Científicas · ESCentre for Biomedical Network Research on Rare Diseases · ESInstituto de Bioquímica Vegetal y Fotosíntesis · ESInstituto de Recursos Naturales y Agrobiología de Salamanca · ESUniversidad de Sevilla · ESUniversity of California, Berkeley · USUniversity of Neuchâtel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavoproteins participate in a wide variety of physiologically relevant processes that typically involve redox reactions. Within this protein superfamily, there exists a group that is able to transfer reducing equivalents from FAD to a redox-active disulfide bridge, which further reduces disulfide bridges in target proteins to regulate their structure and function. We have identified a previously undescribed type of flavin enzyme that is exclusive to oxygenic photosynthetic prokaryotes and that is based on the primary sequence that had been assigned as an NADPH-dependent thioredoxin reductase (NTR). However, our experimental data show that the protein does not transfer reducing equivalents from flavins to disulfides as in NTRs but functions in the opposite direction. High-resolution structures of the protein from

Indexed as

Amino Acid SequenceBacterial ProteinsBinding SitesBiocatalysisCell MembraneCrystallography, X-RayCyanobacteriaDisulfidesFlavin-Adenine DinucleotideGene ExpressionKineticsModels, MolecularOxidoreductasesProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandBacterial ProteinsDisulfidesFlavin-Adenine DinucleotideOxidoreductasesRecombinant ProteinsThioredoxin-Disulfide Reductaseflavoproteinredox active disulfideRossmann foldsulfhydryltransfer of reducing equivalents

Identifiers

PMID29133410
PMCPMC5715778
OpenAlexW2769635007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.